Global antibiotic resistance in Streptococcus pneumoniae

被引:116
作者
Adam, D [1 ]
机构
[1] Univ Munich, Kinderklin, D-80337 Munich, Germany
关键词
D O I
10.1093/jac/dkf801
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The last two decades of the 20th century were marked by an increasing resistance rate among several bacteria. Threat of resistance is present in Staphylococcus spp., Enterococcus spp., Pseudomonas spp. and Enterobacteriaceae, which are the major pathogens in nosocomial infections. In the community, too, increasing resistance can be observed and is attributed mainly (but not exclusively) to Streptococcus pneumoniae and Haemophilus influenzae. To scrutinize this trend, resistance surveillance in the community was established about 10 years ago. One of the multinational, longitudinal surveillance programmes in place is the Alexander Project, which was established in 1992 to monitor the susceptibility of the major community-acquired lower respiratory tract pathogens to a range of antibacterial drugs. The Alexander Project has revealed a tendency towards increasing resistance of S. pneumoniae to penicillin and macrolide therapy. Within Europe, the prevalence of penicillin resistance among S. pneumoniae isolates is particularly high in France and Spain. Macrolide resistance in S. pneumoniae is also a growing problem in European countries such as France, Spain, Belgium and Italy, where the extent of macrolide resistance in S. pneumoniae now exceeds that of penicillin resistance.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 11 条
[1]  
[Anonymous], 2000, OV ANT RES
[2]   Evolving resistance patterns of Streptococcus pneumoniae:: A link with long-acting macrolide consumption? [J].
Baquero, F .
JOURNAL OF CHEMOTHERAPY, 1999, 11 :35-43
[3]   The Alexander Project 1996-1997:: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections [J].
Felmingham, D ;
Grüneberg, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (02) :191-203
[4]  
Felmingham D, 1996, J ANTIMICROB CHEMOTH, V38, P1
[6]   Streptococcus pneunoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997) [J].
Granizo, JJ ;
Aguilar, L ;
Casal, J ;
García-Rey, C ;
Dal-Ré, R ;
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) :767-773
[7]   Results of the Alexander project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens [J].
Gruneberg, RN ;
Felmingham, D ;
Acar, J ;
Lemozy, J ;
Bauernfeind, A ;
Grimm, H ;
Schito, GC ;
Russo, G ;
Baquero, F ;
Louzao, JL ;
Gruneberg, R ;
Murphy, P ;
Neu, H ;
Berk, S ;
Pfaller, M ;
Sewell, D ;
Doern, G .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (04) :169-181
[8]   Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin [J].
Kelley, MA ;
Weber, DJ ;
Gilligan, P ;
Cohen, MS .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1008-1011
[9]   Surveillance studies: how can they help the management of infection? [J].
Masterton, RG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 :53-58
[10]  
*NAT COMM CLIN LAB, 2001, M100S11 NCCLS S